Protalix BioTherapeutics (PLX) Receivables - Other (2010 - 2019)
Protalix BioTherapeutics' quarterly Receivables - Other came in at $26000.0 in Q4 2019, down 99.0% quarter-over-quarter from $2.6 million in Q1 2014.
Protalix BioTherapeutics has reported Receivables - Other for 6 years, with the latest figure at $26000.0 in Q4 2019.
- For the quarter ending Q4 2019, Receivables - Other changed N/A year-over-year to $26000.0; the trailing twelve-month figure through Dec 2019 stood at $26000.0 (changed N/A YoY), and the FY2019 full-year result was $26000.0, changed N/A from the prior year.
- Receivables - Other for Q4 2019 stood at $26000.0, down from $2.6 million in the prior quarter.
- The five-year high for Receivables - Other was $26000.0 in Q4 2019, with the low at $26000.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 26,000.00 |
| Dec 31, 2019 | 26,000.00 |
| Mar 31, 2014 | 2.61 Mn |
| Mar 31, 2014 | 2.61 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Dec 31, 2013 | 1.46 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Sep 30, 2013 | 4.17 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Jun 30, 2013 | 3.59 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Mar 31, 2013 | 3.55 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Dec 31, 2012 | 3.69 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Sep 30, 2012 | 3.28 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Jun 30, 2012 | 4.05 Mn |
| Mar 31, 2012 | 3.15 Mn |
| Mar 31, 2012 | 3.15 Mn |
| Dec 31, 2011 | 3.84 Mn |
| Dec 31, 2011 | 3.84 Mn |
| Sep 30, 2011 | 3.02 Mn |
| Sep 30, 2011 | 3.02 Mn |
| Jun 30, 2011 | 4.88 Mn |
| Jun 30, 2011 | 4.88 Mn |
| Dec 31, 2010 | 2.23 Mn |
| Dec 31, 2010 | 2.23 Mn |